Glycogen storage disease type I: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Anmol}} | ||
'''For patient information click [[Glycogen storage disease type I (patient information)|here]]''' | '''For patient information click [[Glycogen storage disease type I (patient information)|here]]''' | ||
Line 17: | Line 17: | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{SK}} Glucose-6-phosphatase deficiency; Glycogen storage disease type 1; Glycogenosis type 1; Von Gierke's disease; GSD 1 | {{SK}} Glucose-6-phosphatase deficiency; Glycogen storage disease type 1; Glycogenosis type 1; Von Gierke's disease; GSD 1; GSD type 1; Hepatorenal form of GSD | ||
==[[Glycogen storage disease type I overview|Overview]]== | ==[[Glycogen storage disease type I overview|Overview]]== | ||
Line 45: | Line 45: | ||
[[Glycogen storage disease type I medical therapy|Medical Therapy]] | [[Glycogen storage disease type I surgery|Surgery]] | [[Glycogen storage disease type I primary prevention|Primary Prevention]] | [[Glycogen storage disease type I secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type I cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type I future or investigational therapies|Future or Investigational Therapies]] | [[Glycogen storage disease type I medical therapy|Medical Therapy]] | [[Glycogen storage disease type I surgery|Surgery]] | [[Glycogen storage disease type I primary prevention|Primary Prevention]] | [[Glycogen storage disease type I secondary prevention|Secondary Prevention]] | [[Glycogen storage disease type I cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Glycogen storage disease type I future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
:[[Glycogen storage disease type I case study one|Case #1]] | :[[Glycogen storage disease type I case study one|Case #1]] [[Category:Endocrinology]] [[Category:Hepatology]] [[Category:Gastroenterology]] | ||
[[es:Enfermedad de Von Gierke]] | [[es:Enfermedad de Von Gierke]] |
Revision as of 15:34, 30 November 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
For patient information click here Template:DiseaseDisorder infobox
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I |
Synonyms and keywords: Glucose-6-phosphatase deficiency; Glycogen storage disease type 1; Glycogenosis type 1; Von Gierke's disease; GSD 1; GSD type 1; Hepatorenal form of GSD
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glycogen storage disease type I from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies